Related by context. All words. (Click for frequent words.) 68 chronic myeloid leukemia 67 chronic myelogenous leukemia CML 66 chronic myeloid leukemia CML 61 multiple myeloma 61 non Hodgkins Lymphoma 60 leukemia CML 60 leukemia ALL 60 indolent NHL 59 non Hodgkin Lymphoma 59 chronic lymphocytic leukemia 59 indolent lymphoma 59 acute myeloid leukemia 59 chronic lymphocytic leukemia CLL 59 lymphoma 59 Glioblastoma Multiforme 58 Non Hodgkin Lymphoma 58 Gleevec resistant 58 Non Hodgkins lymphoma 58 gastrointestinal stromal tumor 58 brain tumor glioblastoma multiforme 58 hemolytic anemia 58 Non Hodgkin lymphoma 58 leukemia 58 leukemia CLL 58 acute lymphoblastic leukemia 58 leukemia AML 57 acute promyelocytic leukemia 57 glioblastoma 57 Acute Lymphoblastic Leukemia 57 Hodgkin lymphoma NHL 57 Acute Myelogenous Leukemia AML 57 alveolar rhabdomyosarcoma 57 Acute Myelogenous Leukemia 57 Non Hodgkins Lymphoma 57 non Hodgkin lymphoma 57 Hodgkin Disease 57 acute myeloid leukemia AML 56 imatinib resistant 56 Glioblastoma 56 synovial sarcoma 56 acute myelogenous leukemia 56 acute myelogenous leukemia AML 56 imatinib Gleevec 56 gastrointestinal stromal tumors 56 metastatic colon cancer 56 refractory chronic myeloid 56 Wegener granulomatosis 56 multiple myeloma MM 56 lymphoblastic leukemia 56 leukemias 55 Burkitt lymphoma 55 Myelodysplastic Syndrome 55 Cholangiocarcinoma 55 non Hodgkin lymphomas 55 diffuse intrinsic pontine glioma 55 acute leukemias 55 lymphoblastic lymphoma 55 refractory CML 55 gastrointestinal stromal tumor GIST 55 Non Hodgkin 55 leukemic 55 imatinib Gleevec ® 55 Glioblastoma multiforme GBM 55 lymphocytic leukemia 55 Follicular lymphoma 55 follicular NHL 54 carcinoid cancer 54 systemic anaplastic large 54 Ph + CML 54 Acute Lymphocytic Leukemia 54 glioblastoma multiforme GBM 54 Hodgkin lymphoma 54 myelogenous leukemia 54 myelodysplasia 54 follicular lymphoma 54 hematological malignancy 54 Acute Myeloid Leukaemia AML 54 Chronic lymphocytic leukemia 54 chronic myeloid 54 myelodysplastic syndrome MDS 54 mycosis fungoides 54 relapsed leukemia 54 Chronic Myeloid Leukemia 54 Acute myeloid leukemia 54 gastrointestinal stromal tumors GIST 54 Rituxan rituximab 54 anaplastic 54 Philadelphia Chromosome Positive 54 relapsed refractory 54 acute GvHD 54 MALT lymphoma 54 dasatinib Sprycel 54 medulla blastoma 54 embryonal rhabdomyosarcoma 54 Ewing sarcoma rare 54 PCNSL 54 non Hodgkins lymphoma 54 leiomyosarcoma 53 Ph + ALL 53 Hodgkin Lymphoma 53 smoldering myeloma 53 Ph + 53 Gleevec imatinib mesylate 53 metastatic malignant melanoma 53 myelodysplastic syndrome 53 acute lymphoblastic 53 tyrosine kinase inhibitors TKIs 53 neuroblastoma 53 Chronic Myeloid Leukemia CML 53 Acute Leukemia 53 Ph + acute lymphoblastic 53 non hodgkin lymphoma 53 T#I [002] 53 acute leukemia 53 Ewing sarcoma 53 acute myeloid 53 Burkitt Lymphoma 53 Ewing Sarcoma 53 malignant pleural mesothelioma 53 hematological cancers 53 sarcoma 53 hypereosinophilic syndrome 53 cell lymphoma CTCL 53 severe aplastic anemia 53 pancreatic adenocarcinoma 53 glioblastoma multiforme 53 hemophagocytic lymphohistiocytosis 53 cancer 53 imatinib resistance 53 astrocytoma 53 Ewing Sarcoma rare 53 Leukemias 53 Acute Myeloid Leukemia 52 dasatinib 52 Mantle Cell Lymphoma 52 Chronic Myelogenous Leukemia 52 Lymphoma 52 Chronic lymphocytic leukemia CLL 52 myelofibrosis polycythemia vera 52 angiosarcoma 52 medulloblastoma 52 metastatic melanoma 52 Gleevec imatinib 52 cell acute lymphoblastic 52 Hodgkins Lymphoma 52 myelofibrosis 52 adenoid cystic carcinoma 52 non hodgkins lymphoma 52 PTLD 52 refractory cutaneous T 52 cediranib 52 recurrent glioblastoma multiforme 52 papillary carcinoma 52 eosinophilic esophagitis 52 Myelodysplastic Syndrome MDS 52 idiopathic thrombocytopenic purpura ITP 52 Chronic Lymphocytic Leukemia CLL 52 recurrent glioblastoma multiforme GBM 52 interstitial pulmonary fibrosis 52 essential thrombocythemia 52 anaplastic astrocytoma 52 Krabbe disease 52 Chronic Myelogenous Leukemia CML 52 CVP cyclophosphamide vincristine 52 erlotinib Tarceva ® 52 myelodysplastic syndromes 52 Wilms Tumor 52 idiopathic thrombocytopenic purpura 52 CLL 52 differentiated thyroid 52 indolent follicular non 52 Zolinza 52 pediatric malignancies 52 atypical rhabdoid tumor 52 relapsed mantle 52 Rhabdomyosarcoma 52 myeloproliferative neoplasms MPNs 52 CHOP chemotherapy 51 Chronic myeloid leukemia 51 systemic lupus erythematosus SLE 51 chronic granulomatous disease 51 vasculitis 51 Pathway Inhibitor 51 tumors GIST 51 allogeneic bone marrow 51 atypical hemolytic uremic syndrome 51 leukaemias 51 Glioblastoma multiforme 51 idiopathic pulmonary fibrosis IPF 51 diabetic kidney 51 Chronic Myeloid Leukaemia 51 bevacizumab Avastin ® 51 lupus nephritis 51 Chronic Lymphocytic Leukemia 51 myeloproliferative disorder 51 thalidomide Thalomid 51 pertuzumab 51 adrenal cortical carcinoma 51 hematological malignancies 51 Hodgkin lymphoma HL 51 HER2 overexpression 51 lymphoma CTCL 51 cutaneous T 51 Hurler syndrome 51 refractory chronic lymphocytic 51 Niemann Pick disease 51 neuroendocrine cancers 51 acute promyelocytic leukemia APL 51 hepatitis C viral infection 51 imatinib 51 hematologic disorders 51 leukemia APL 51 refractory indolent non 51 seminoma 51 Zarnestra 51 carcinoid 51 Osteosarcoma 51 galiximab 51 Hodgkin disease 51 non squamous 51 acute lymphocytic leukemia 51 previously untreated follicular 51 Ewings Sarcoma 51 Waldenstrom macroglobulinemia 51 cetuximab Erbitux ® 51 cytogenetic responses 51 metastatic malignant 51 systemic mastocytosis 51 Acute Myeloid Leukaemia 51 hematological diseases 51 Hodgkins lymphoma 51 T#I mutation 51 imatinib therapy 51 Anaplastic 51 myeloid leukemia 51 Acute lymphoblastic leukemia 51 relapsed multiple myeloma 51 TTF Therapy 51 lupus 51 Myelofibrosis 51 Bcr Abl T#I mutation 51 Acute Myeloid Leukemia AML 50 blastic 50 Ribavirin causes 50 hypophosphatasia 50 hA# 50 dyskeratosis congenita 50 FSGS 50 basiliximab 50 steroid refractory GvHD 50 transplanted bone marrow 50 relapsed ovarian cancer 50 systemic lupus erythematosus 50 cystic fibrosis 50 Neuroblastoma 50 B CLL 50 cell malignancies 50 osteogenic sarcoma 50 BRAF inhibitor 50 bile duct cancer 50 Omacetaxine 50 HCV infection 50 ADPKD 50 mutated KRAS 50 Imatinib 50 BCR ABL 50 neuroendocrine tumors 50 malignant ascites 50 hepatorenal syndrome 50 myasthenia gravis neuromuscular 50 Wilm Tumor 50 Acute myeloid leukemia AML 50 rhabdomyosarcoma 50 grade gliomas 50 sorafenib Nexavar ® 50 cell lymphoma 50 myotonic dystrophy 50 breast carcinomas 50 Krabbe Disease 50 nonsmall cell lung cancer 50 relapsed refractory aggressive 50 nilotinib 50 immune thrombocytopenic purpura 50 Dasatinib 50 ON #.Na 50 post transplant lymphoproliferative 50 Velcade bortezomib 50 HER2 positive metastatic breast 50 metastatic colorectal cancer 50 pediatric acute lymphoblastic 50 refractory AML 50 eosinophilic asthma 50 Cell Lymphoma 50 recurrent glioblastoma 50 myeloproliferative neoplasms 50 ifosfamide 50 inoperable pancreatic cancer 50 ependymoma 50 Ceflatonin R 50 precancerous condition 50 visilizumab 50 vemurafenib 50 GISTs 50 metastatic kidney 50 enzastaurin 50 juvenile myelomonocytic leukemia 50 metastatic cancer 50 Treanda 50 squamous cell carcinoma SCC 50 relapsing remitting 50 blastoma 50 melanoma 50 Fanconi anemia 50 polycystic kidney disease 50 KRAS wild 50 Wilms tumor 50 colorectal cancer liver metastases 50 JAK2 inhibitor 50 iniparib 50 JMML 49 pontine glioma 49 refractory gout 49 T#I mutant 49 Testicular cancer 49 CML CP 49 multiforme 49 Pixantrone 49 pemphigoid 49 Crizotinib 49 Aplidin 49 cystic fibrosis CF 49 lymphatic cancer 49 T Cell Lymphoma 49 lymphoma leukemia 49 lumiliximab 49 tigecycline 49 Metastatic melanoma 49 myeloid metaplasia 49 Hodgkins Disease 49 GvHD 49 Idiopathic Thrombocytopenic Purpura ITP 49 abiraterone 49 EGFR inhibitors 49 azacytidine 49 angiogenesis inhibitor 49 type 1diabetes 49 Acute myelogenous leukemia 49 basal cell carcinoma BCC 49 Epratuzumab 49 lymphomas 49 Von Willebrand disease 49 medulloblastoma malignant brain tumor 49 diabetic nephropathy 49 solid tumors 49 carcinoid tumors 49 myeloproliferative disorders 49 gefitinib Iressa 49 idiopathic pulmonary fibrosis 49 relapsed Acute Myeloid 49 YONDELIS 49 AML acute myeloid 49 neurofibromatosis 49 thymic carcinoma 49 SPRYCEL ® 49 hematologic malignancies 49 myotonic muscular dystrophy 49 metastatic renal cell carcinoma 49 nephrotic syndrome 49 DFMO 49 autoimmune hemolytic anemia 49 organ transplant rejection 49 crizotinib 49 PNP inhibitor 49 relapsed acute lymphoblastic 49 Amyotrophic lateral sclerosis 49 epithelial tumors 49 pleural mesothelioma 49 Multiple Myeloma 49 Leber Congenital Amaurosis LCA 49 proteasome inhibitor bortezomib 49 malignant lymphoma 49 castration resistant prostate cancer 49 antigen CD# 49 Diffuse Large B 49 debilitating autoimmune 49 cetuximab Erbitux 49 pancreatic NET 49 CYT# potent vascular disrupting 49 imatinib mesylate 49 IV metastatic melanoma 49 spinal muscular atrophy SMA 49 Tasigna nilotinib 49 cell lymphomas 49 relapsing remitting multiple sclerosis 49 histone deacetylase HDAC inhibitor 49 tyrosine kinase inhibitors 49 intravenous belinostat 49 HGS ETR1 49 GIST 49 MyVax R 49 Graft Versus Host 49 pomalidomide 49 Lou Gerhig disease 49 renal cell carcinoma 49 Crohn disease 49 hepatitis C HCV 49 metastatic colorectal 49 nonalcoholic steatohepatitis NASH 49 Advexin 49 Crohns disease 49 docetaxel chemotherapy 49 neuroblastoma tumors 49 infantile spasms 49 autosomal dominant polycystic kidney 49 TACI Ig 49 refractory Hodgkin 49 Gorlin syndrome 49 MELAS 49 radioimmunotherapeutic agent 49 diagnose Alzheimer disease 49 relapsed 49 antiestrogen therapy 49 Bosutinib 49 basal cell nevus syndrome 49 1 diabetes T1D 49 infectious mononucleosis 49 receptor tyrosine kinase inhibitor 49 myeloablative 49 DLBCL 49 Follicular Lymphoma 49 allogeneic HSCT 49 Rituximab 49 oligodendroglioma 49 thymoma 49 gastrointestinal stromal tumors GISTs 49 Carcinoid tumors 49 kidney disease 48 NSCLC 48 leukoencephalopathy 48 resistant ovarian cancer 48 metastatic lung cancer 48 retinoblastoma 48 Acute Lymphoblastic Leukaemia 48 B Cell Lymphoma 48 intra arterial chemotherapy 48 IL# PE#QQR 48 systemic scleroderma 48 Maroteaux Lamy Syndrome 48 neuroblastoma tumor 48 AML Leukemia 48 Cutaneous T 48 Malignant pleural mesothelioma 48 medulloblastomas 48 subependymal giant cell 48 2 diabetes T2D 48 hormone refractory prostate cancer 48 prostate cancer HRPC 48 superficial bladder cancer 48 neuro endocrine tumors 48 follicular Non Hodgkin 48 MyVax 48 pancreatic carcinoma 48 Enzastaurin 48 colon cancer 48 malignant fibrous histiocytoma 48 Hepatocellular Carcinoma HCC 48 hepatoblastoma 48 mitochondrial myopathy 48 Glioblastoma Multiforme GBM 48 neurofibroma 48 alvespimycin 48 pulmonary hypertension PH 48 Genentech Rituxan 48 Hutchinson Gilford Progeria Syndrome 48 Ceflatonin 48 nasopharyngeal cancer 48 Telcyta 48 diffuse pontine glioma 48 myeloid 48 Chronic myeloid leukemia CML 48 malignant melanoma 48 rituximab refractory 48 systemic ALCL 48 standard chemotherapy regimens 48 mTOR inhibitor 48 metastatic uveal melanoma 48 hematologic cancers 48 Brentuximab Vedotin SGN 48 TACE 48 inflammatory arthritis 48 sickle cell disease 48 malignant lymphomas 48 tumors 48 nephritis 48 precursor acute lymphoblastic 48 evaluating tivozanib 48 Onco TCS 48 sunitinib Sutent ® 48 cholangiocarcinoma 48 Vidaza azacitidine 48 lymphocytic 48 AMN# [001] 48 FOLFOX chemotherapy 48 stem cell transplant 48 pancreatic cancer 48 bone marrow 48 TREANDA 48 neuronal ceroid lipofuscinosis NCL 48 leiomyosarcoma rare 48 figitumumab 48 hematological cancers notably 48 cell carcinoma 48 inherited neurodegenerative disorder 48 CD# mAb 48 Lafora disease 48 gouty arthritis 48 Chronic Fatigue Syndrome CFS 48 humanised monoclonal antibody 48 irinotecan chemotherapy 48 recurrent glioma 48 Pompe Disease 48 pazopanib 48 BRAF V#E mutation 48 primitive neuroectodermal tumor 48 transplantation HCT 48 Duchenne muscular dystrophy DMD 48 capecitabine Xeloda 48 dermatofibrosarcoma protuberans 48 cancerdefine 48 nucleotide analog 48 Behcet disease 48 HER2 positive breast cancer 48 heavily pretreated 48 polycystic kidneys 48 lymphangioleiomyomatosis LAM 48 dilated aorta 48 infection progressive multifocal 48 bortezomib Velcade R 48 Pleural mesothelioma 48 Idiopathic Pulmonary Fibrosis 48 Cotara ® 48 Inflammatory breast cancer 48 dasatinib Sprycel ® 48 Gleevec 48 paraganglioma 48 ptau 48 vWD 48 invasive lobular carcinoma 48 malignancies 48 Medulloblastoma 48 Vidaza ® 48 cetuximab Erbitux R 48 AA amyloidosis 48 chronic GVHD 48 neovascular diseases 48 GIST tumors 48 nutlin 3a 48 Metastatic breast cancer 48 osteosarcoma rare 48 Wiskott Aldrich Syndrome 48 liposarcoma 48 prednisolone chemotherapy 48 myeloma 48 histiocytosis 48 squamous cell lung cancer 48 angiogenesis inhibition 48 cancer mCRC 48 brain tumor glioblastoma 48 Myelodysplastic Syndromes MDS 48 FLT3 48 Cabazitaxel 48 serous ovarian cancer 48 Eliezer Zomer Ph.D. 48 tonsillar cancer 48 mastocytosis 48 cutaneous T cell 48 Alessandro Riva 48 non nucleoside inhibitor 48 interferon pathway 48 glioblastoma tumors 48 alkylating agent 48 tuberous sclerosis 48 acute myelogenous 48 cell sarcoma 47 non metastatic osteosarcoma 47 colorectal liver metastases 47 Sjögren syndrome 47 allogeneic stem cell 47 nasal pharyngeal cancer 47 Fludarabine 47 haematological cancers 47 IV melanoma 47 nonmelanoma skin cancers 47 tafamidis 47 cell lymphoma ALCL 47 pancreatic tumor 47 tumor 47 antimetabolite 47 Spinal Muscular Atrophy SMA 47 anticancer therapy 47 JAK inhibitor 47 OncoVEX GM CSF 47 Bcr Abl mutations 47 Sanfilippo Syndrome 47 TTR amyloidosis 47 peritumoral brain edema 47 cilengitide 47 mapatumumab 47 metastatic osteosarcoma 47 peritoneal cancer 47 aHUS 47 blastic phase 47 Hurler Syndrome 47 Leukemia 47 refractory metastatic 47 HRPC 47 relapsed MM 47 DIPG 47 SOD1 gene 47 GSK3 47 CVP chemotherapy 47 ganetespib 47 steroid refractory ulcerative 47 chronic eosinophilic leukemia 47 purpura ITP 47 Relapsed Refractory 47 myeloproliferative 47 amyotrophic lateral sclerosis ALS 47 fatal neurodegenerative 47 thyroiditis 47 Th1 cells 47 Amyotrophic lateral sclerosis ALS 47 lenalidomide Revlimid R 47 HNSCC 47 nucleoside analogs 47 blood clotting disorder 47 MGUS 47 chemotherapy 47 proteasome inhibitors 47 mepolizumab 47 prostate cancer PCa 47 refractory ovarian cancer 47 soft tissue sarcoma 47 castration resistant 47 Folotyn 47 oral clodronate 47 EGFr 47 allograft rejection 47 hepatocellular cancer 47 rhabdoid 47 metastasized melanoma 47 treating chronic myeloid 47 metastatic renal cell 47 autoimmune 47 mucinous 47 castrate resistant prostate cancer 47 Relapsed Refractory Aggressive 47 colorectal cancer CRC 47 Novartis Gleevec 47 membranous nephropathy 47 malignancy 47 Waldenstrom Macroglobulinemia 47 taxane chemotherapy 47 infantile onset 47 bendamustine 47 metastatic prostate cancer 47 follicular lymphoma FL 47 hormone refractory 47 Pompe disease 47 interstitial cystitis IC 47 imatinib mesylate Gleevec 47 myelofibrosis MF 47 Multiple Myeloma MM 47 Anthracycline 47 cabazitaxel 47 CLL SLL 47 squamous cell cancer 47 Non Hodgkin Lymphomas 47 PEGylated Fab fragment 47 Synovial Sarcoma 47 immune thrombocytopenic purpura ITP 47 marrow transplant 47 colorectal carcinoma 47 chromosomal translocation 47 elacytarabine 47 SCCHN 47 primary sclerosing cholangitis 47 lung fibrosis 47 gastrointestinal GI cancers 47 peritoneal carcinomatosis 47 Carcinoma 47 hematopoietic disorders 47 Sprycel 47 synovial sarcoma rare 47 Cholinesterase inhibitors 47 haematologic 47 polyneuropathy CIDP 47 adrenocortical carcinoma 47 thrombotic thrombocytopenic purpura 47 familial ALS 47 BAY #-# 47 systemic fungal infections 47 histologies 47 cystic fibrosis hereditary 47 demonstrated antitumor activity 47 allogeneic hematopoietic stem cell 47 interferon therapy 47 leukemic stem cells 47 Systemic lupus erythematosus SLE 47 Folfox 47 hematopoietic cancers 47 amyloidosis 47 hepatic toxicity 47 panitumumab Vectibix 47 refractory NSCLC 47 Herceptin trastuzumab 47 refractory myeloma 47 immunosuppressive therapies 47 esophageal adenocarcinoma 47 Azedra 47 Personalized Immunotherapy 47 cell carcinoma RCC 47 NPM1 47 chlorambucil 47 ulcerative colitis 47 MabThera Rituxan 47 atypical Hemolytic Uremic Syndrome 47 Candida infection 47 squamous cell 47 Epstein Barr Virus 47 microvascular angina 47 Gleevac 47 complete cytogenetic 47 rheumatoid arthritis 47 neuroendocrine cancer 47 mycophenolate mofetil 47 pancreatic cancers 47 grade glioma 47 relapsing MS 47 Inflammatory Breast Cancer 47 Aflibercept 47 BRAF V# mutation 47 frontotemporal dementia 47 investigational monoclonal antibody 47 malignant growths 47 Sudhir Agrawal D.Phil 47 Pemetrexed 47 cisplatin resistant 47 IRX 2 47 lymphoproliferative disorder 47 acute leukemia AML 47 precancerous cervical lesions 47 Campath alemtuzumab 47 diabetes mellitus DM 47 MPGN 47 APOL1 47 Troxatyl 47 cyclophosphamide doxorubicin vincristine 47 Toxicities 47 GRN#L 47 neuro degenerative disorder 47 Annamycin 47 Wilm tumor 47 Natalizumab 47 acyclovir Lauriad R 47 potentially hepatotoxic 47 relapsed refractory multiple myeloma 47 leukaemic stem cells 47 Nephrotic syndrome 47 liver cancer 47 brainstem glioma 47 alveolar soft 47 glioblastoma brain tumor 47 proteasome inhibitor 46 Rituxan 46 Romiplostim 46 Leber Hereditary Optic Neuropathy 46 cancers 46 ponatinib 46 TKIs 46 WT1 46 prostate tumors 46 hepatocellular carcinoma 46 deletion 5q 46 Xcytrin 46 irinotecan doxorubicin oxaliplatin paclitaxel 46 rhabdomyosarcoma rare 46 commercialize deforolimus 46 aplastic anemia rare 46 Ofatumumab 46 polycythemia vera 46 Ewing sarcoma bone 46 Rheumatoid Arthritis RA 46 rituximab Rituxan 46 BENLYSTA TM 46 antigen PSA 46 grade cervical intraepithelial 46 Canavan Disease 46 idarubicin 46 immunosuppressant drug 46 Ewings sarcoma 46 Behcet syndrome 46 kidney urologic 46 ovarian carcinoma 46 Amrubicin 46 invasive ductal 46 5q deletion 46 Revlimid lenalidomide 46 antibody MAb 46 carcinoma 46 relapsing remitting MS RRMS 46 relapsed indolent NHL 46 fibromatosis 46 Rhabdomyosarcoma rare 46 chronic lymphatic leukemia 46 VEGF inhibitors 46 Juvenile Rheumatoid Arthritis 46 metastatic CRC 46 bone marrow transplant 46 sorafenib tablets 46 Kit CD# positive 46 tuberous sclerosis complex 46 Navelbine 46 ATTR PN 46 Adjuvant chemotherapy 46 transplantation HSCT 46 refractory CLL 46 carcinoid tumor 46 myelodysplastic myeloproliferative diseases 46 PLX# 46 gastric cancers 46 bullous 46 Malignant mesothelioma 46 Li Fraumeni Syndrome 46 Host Disease GvHD 46 zalutumumab 46 tumor metastases 46 talabostat 46 psoriasis rheumatoid arthritis 46 EGFR expressing mCRC 46 mCRC patients 46 Friedreich ataxia 46 Nexavar sorafenib 46 smoldering multiple myeloma 46 Severe Primary IGFD 46 lupus scleroderma 46 pseudotumor cerebri 46 anthracycline taxane 46 autoimmune hepatitis 46 Arranon 46 autoimmune disease 46 retinoblastoma rare 46 bone marrow transplants 46 erlotinib Tarceva 46 molecularly targeted 46 Nilotinib 46 advanced nonsquamous NSCLC 46 Guillain Barré Syndrome 46 sorafenib Nexavar 46 NSCL cancer 46 Wiskott Aldrich syndrome 46 FVIII inhibitors 46 Myelodysplastic syndrome 46 mycobacterium tuberculosis 46 small lymphocytic lymphoma 46 GW# [003] 46 Alemtuzumab 46 relapsed acute myelogenous 46 osteosarcoma 46 CMV infections 46 OncoVex 46 lymphoid malignancies 46 steroid prednisone 46 panobinostat 46 irinotecan containing 46 TKI therapy 46 fungoides 46 Cryptococcus neoformans 46 Arzerra ofatumumab 46 Stargardt disease 46 ZACTIMA TM ZD# 46 achieve sustained virologic 46 anti angiogenic agents 46 hematological 46 neurodegenerative disorder 46 myeloproliferative disease 46 prostate cancer mCRPC 46 myeloproliferative diseases 46 acute lymphatic leukemia 46 focal segmental glomerulosclerosis 46 hypoxia inducible factor 46 tumoral 46 transgenic rats 46 motesanib 46 Revlimid pill 46 Amyloidosis 46 Etanercept 46 B lymphocytes 46 Telintra 46 severe oral mucositis 46 haematological 46 dexanabinol 46 diagnosed Ph + 46 progressive supranuclear palsy 46 ovarian cancer 46 astrocytomas 46 Leukine ® 46 lung cancer 46 cardiac channelopathies 46 necrotizing pneumonia 46 recurrent ovarian cancer 46 PARP inhibitors 46 Cinquil 46 aflibercept VEGF Trap 46 HCV infections 46 refractory CTCL 46 Panzem NCD 46 refractory colorectal cancer 46 systemic amyloidosis 46 lymphoid tissue 46 depsipeptide 46 channelopathy 46 S. aureus infections 46 ALS Amyotrophic Lateral Sclerosis 46 autoimmune pancreatitis 46 hypomethylating agents 46 neoplastic 46 radioimmunotherapy 46 lupus erythematosus 46 tuberous sclerosis TS 46 OSI Tarceva 46 ELACYT 46 BRCA deficient 46 mycophenolate mofetil MMF 46 milatuzumab 46 pleomorphic 46 systemic juvenile idiopathic 46 Sanfilippo syndrome 46 pancreatic endocrine 46 temozolomide Temodar 46 renal carcinoma 46 Bayer Nexavar 46 Muraglitazar 46 invasive candidiasis 46 HNPCC 46 Synovial sarcoma 46 Alport syndrome 46 anaplastic large 46 cell lymphoma DLBCL 46 Dravet syndrome 46 nucleoside analogues 46 stem cell engraftment 46 HGS# 46 gemcitabine carboplatin 46 aplastic anemia 46 Benign breast 46 Alzheimer Disease AD 46 mRCC 46 esophageal candidiasis 46 cell lung cancer 46 CPOP R 46 maribavir 46 anthracyclines taxanes 46 chemotherapeutic agent 46 HuMax CD4 46 sunitinib 46 SNT-MC#/idebenone 46 BRAF gene 46 baminercept 46 bortezomib 46 ZACTIMA 46 Ulcerative Colitis 46 stage IIIb IV 46 demethylating agents 46 Acute Leukaemia 46 refractory SCLC 46 Interferon alpha 46 malignant pleural mesothelioma MPM 46 scleroderma chronic 46 relapsed AML 46 orchitis 46 bone metastasis 46 Sprycel dasatinib 46 medullary thyroid cancer 46 monoclonal antibody therapies 46 bronchopulmonary dysplasia 46 GVHD 46 LymphoStat B TM 46 Multiple myeloma 46 Duchenne Muscular Dystrophy 46 phase Ph + 46 mediated immunity 46 Fludara ® 46 virotherapy 46 Psoriatic arthritis 46 macroglobulinemia 46 vismodegib 46 ANCA associated 46 malignant mesothelioma